General
| Peptide: | G2 |
| Microorganism: | Streptococcus mutans |
| Administration: | |
| Stage: | Preformed biofilm |
| Notes: | S. mutans clinical isolate UA140 |
Experimental procedure
| Method | AMP Effect(Biofilm reduction) | Concentration | Notes |
|---|---|---|---|
| Resazurin assay | <= 20 % | 50 uM | |
| Resazurin assay | 21 - 50% | 100 uM |
Reference
- R. Sullivan, P. Santarpia, S. Lavender, E. Gittins, Z. Liu, M.H. Anderson, J. He, W. Shi, R. Eckert Clinical Efficacy of a Specifically Targeted Antimicrobial Peptide Mouth Rinse: Targeted Elimination of Streptococcus mutans and Prevention of Demineralization
M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.
Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or gpmaccari@gmail.com